"Specializing in the integration and optimization of scientific and corporate decision-making processes related to toxicology in the pharmaceutical, chemical, and agrochemical industries"

Phenotypic Analysis of Genetically Altered Mice

    • Evaluate genetic alteration and recommend optimized approach based on anticipated tissue/organ effects
    • Design protocols for methods required (histology, immunohistochemistry, clinical chemistry, hematology, etc.)
    • Review, correlate, and interpret findings
    • Prepare summary report with recommendations for path forward

Benefit: A complete understanding of how the genetic alteration impacts organs increases the predictive value regarding therapeutic potential as well as potential toxicities

Characterization of Animal Models of Human Disease
    • Evaluate animal models for diseases such as osteoarthritis, asthma, and cancer and recommend optimized approach to assessment
    • Review methods of model generation to anticipate inherent complications to interpretation
    • Design protocols for methods required (histology, histochemical stains, clinical chemistry, hematology, etc.)
    • Review, correlate and interpret findings
    • Collaborate with investigators to integrate features of the model with pharmacologic and/or behavioral endpoints
    • Prepare summary report with recommendations for path forward
Benefit: A complete understanding of the model relative to the actual human disease enhances decision making related to interpreting efficacy study findings


Design and Interpretation of Proof-of-Principle (POP) Studies
    • Develop with investigators a hypothesis-based study design using in vivo models
    • Design protocols for required methods (histology, histochemical stains, clinical chemistry, hematology, etc).
    • Review methods of model generation to anticipate inherent complications to interpretation
    • Review, correlate, and interpret findings
    • Prepare summary report with recommendations for path forward
Benefit: The accurate interpretation of well-developed POP studies empowers the decision making process for recommending a path forward into development


Evaluate RNA/Protein Expression in Target Tissues
    • Review target/receptor data and recommend optimized approach to assessment in human and/or animal organs based on anticipated expression patterns
    • Evaluate expression patterns in slides and/or review reports using immunohistochemistry or in situ hybridization detection methods
    • Review and interpret findings (versus artifacts or nonspecific tissue reactions) in relationship to pharmacology and/or toxicity
    • Prepare summary report with recommendations for path forward
Benefit: A clear understanding of RNA/protein tissue expression patterns related to therapeutic targets increases the predictive value regarding therapeutic potential as well as potential toxicities


Evaluate Histochemistry, Ultrastructure,
or Morphometry Data Sets
    • Discuss with investigators the objective of the study
    • Critically review histology slides, micrographs, and/or reports using these methods
    • Evaluate relevance of findings (versus artifacts or nonspecific tissue reactions) in relationship to pharmacology and/or toxicity
    • Prepare summary report with recommendations for path forward
Benefit: The accurate interpretation of special techniques data clarifies the mechanism of organ toxicity in relationship to pharmacology and/or toxicology, and possible human relevance
 

Stratoxon LLC
1853 William Penn Way, Lancaster, PA 17601
Phone:717-735-3646 • 717-735-3647 Fax: 717-293-4470

info@stratoxon.com

© Stratoxon LLC. All rights reserved.